Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist's Medication Recommendations

Camp Hill, Pennsylvania Survey Completed on 01-16-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that the licensed pharmacist's report of medication irregularities was reviewed and acted upon in a timely manner for two residents. Resident 29, who had diagnoses including hypertension and anxiety disorder, was prescribed Quetiapine Fumarate for anxiety, depression, and insomnia. A Medication Regimen Review (MRR) conducted on August 11, 2024, recommended a trial dose reduction of Seroquel. However, the recommendation was not signed by the physician until October 31, 2024, and was never implemented as of January 14, 2025. The Director of Nursing (DON) expressed that the MRR should have been responded to and implemented timely. Similarly, Resident 74, diagnosed with major depressive disorder, anxiety disorder, and dementia, was prescribed Quetiapine Fumarate for depression. An MRR on August 8, 2024, recommended evaluating the routine antipsychotic use for potential dose reduction or discontinuation, and another MRR on August 11, 2024, suggested a trial dose reduction. The physician agreed with the recommendation on October 29, 2024, but the recommendation was not implemented by January 14, 2025. The DON indicated that MRRs should be reviewed and implemented timely by nursing and/or the physician.

Plan Of Correction

DRR for resident 29 with date of 8/11/24 was reviewed by MD and order was placed. DRR for resident 74 with date of 8/8/24 and 8/11/24 were reviewed by MD and orders placed. A Comprehensive review of DRR for the last 2 months will be reviewed to ensure that the MD has reviewed and any new orders implemented. The facility will take further steps to ensure that the problem does not re-occur by in-servicing Unit managers / RN Supervisors on F Tag 756 and facility policy "Medication Regimen Review". Compliance will be monitored by the Director of Nursing / Designee through the DRR Audit of 5 residents weekly x 3 weeks then monthly x 2 months to ensure that the DRR recommendations were reviewed with MD and acted upon, with audit results being forwarded to the QAA committee to determine the need for further follow up / monitoring.

An unhandled error has occurred. Reload 🗙